{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T09:13:40Z","timestamp":1776244420042,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sex hormones can influence susceptibility to multiple sclerosis (MS). Around 400\u00a0million women worldwide use hormonal contraceptives (HC), which contain synthetic versions of female sex hormones. Evidence on HC use and MS risk is inconclusive. The aim of this study was to synthesise studies on the association between prescribed HC and the risk of MS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Medline, Embase, Cochrane library and grey literature were systematically searched on 7th November 2024. Two reviewers independently screened, extracted data and appraised each study\u2019s quality using the Joanna Briggs Institute critical appraisal tool. Pre-determined criteria were used to differentiate between high- and low-quality studies. Random-effects meta-analysis was conducted for studies providing the same effect measure; heterogeneity was assessed. Sensitivity analyses included only high-quality studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Eleven studies were included, six of these were cohort and five were case-control. Three studies were deemed high-quality. Five of the studies found no significant association between HC use and MS risk, four found a decreased risk, and two found an increased risk. Meta-analysis of the unadjusted odds ratio (OR) showed a significantly increased risk of MS with HC use of 1.28 (95% CI 1.08\u20131.52). However meta-analysis of adjusted ORs and sensitivity analyses showed no significant association. Heterogeneity was high.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>No statistically significant association between HC use and MS risk was observed. The meta-analyses indicate a possible increased risk warranting further investigation. Given that heterogeneity was high and only three of the included studies were classed as high-quality, a well-designed study is needed to clarify this association.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10072-026-08953-1","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T03:33:17Z","timestamp":1773372797000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The association between prescribed hormonal contraception and multiple sclerosis risk: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"47","author":[{"given":"Jessica","family":"McDonald","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priya","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Tench","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Dobson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radu","family":"Tanasescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Gran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6384-2342","authenticated-orcid":false,"given":"Bruno","family":"Gran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"key":"8953_CR1","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000622","author":"J Oh","year":"2018","unstructured":"Oh J, Vidal-Jordana A, Montalban X (2018) Multiple sclerosis: clinical aspects. Curr Opin Neurol. https:\/\/doi.org\/10.1097\/WCO.0000000000000622","journal-title":"Curr Opin Neurol"},{"issue":"5","key":"8953_CR2","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/S1474-4422(10)70064-8","volume":"9","author":"N Koch-Henriksen","year":"2010","unstructured":"Koch-Henriksen N, S\u00f8rensen PS (2010) The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 9(5):520\u2013532","journal-title":"Lancet Neurol"},{"key":"8953_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2020.612953","author":"L Ferr\u00e8","year":"2020","unstructured":"Ferr\u00e8 L, Filippi M, Esposito F (2020) Involvement of genetic factors in multiple sclerosis. Front Cell Neurosci. https:\/\/doi.org\/10.3389\/fncel.2020.612953","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"8953_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.13819","volume":"26","author":"R Dobson","year":"2019","unstructured":"Dobson R, Giovannoni G (2019) Multiple sclerosis \u2013 a review. Eur J Neurol 26(1):27\u201340","journal-title":"Eur J Neurol"},{"issue":"11","key":"8953_CR5","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1136\/jnnp-2013-304951","volume":"84","author":"S Menon","year":"2013","unstructured":"Menon S, Shirani A, Zhao Y, Oger J, Traboulsee A, Freedman MS et al (2013) Characterising aggressive multiple sclerosis. J Neurol Neurosurg Psychiatry 84(11):1192\u20138","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"8953_CR6","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1177\/1352458514528266","volume":"20","author":"M Tintore","year":"2014","unstructured":"Tintore M, Tur C (2014) Understanding the role of gender and hormones in multiple sclerosis. Mult Scler J 20(5):518\u2013519","journal-title":"Mult Scler J"},{"issue":"1","key":"8953_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/imm.13004","volume":"156","author":"MC Ysrraelit","year":"2019","unstructured":"Ysrraelit MC, Correale J (2019) Impact of sex hormones on immune function and multiple sclerosis development. Immunology 156(1):9\u201322","journal-title":"Immunology"},{"issue":"1\u20132","key":"8953_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000494262","volume":"80","author":"M Avila","year":"2018","unstructured":"Avila M, Bansal A, Culberson J, Peiris AN (2018) The role of sex hormones in multiple sclerosis. Eur Neurol 80(1\u20132):93\u201399","journal-title":"Eur Neurol"},{"issue":"24","key":"8953_CR9","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1001\/jama.2021.21392","volume":"326","author":"S Teal","year":"2021","unstructured":"Teal S, Edelman A (2021) Contraception selection, effectiveness, and adverse effects: a review. JAMA 326(24):2507\u20132518","journal-title":"JAMA"},{"key":"8953_CR10","unstructured":"Cooper DB, Patel P (2025) Oral Contraceptive Pills. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright \u00a9 2025. StatPearls Publishing LLC."},{"issue":"2","key":"8953_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/13625180410001715681","volume":"9","author":"SO Skouby","year":"2004","unstructured":"Skouby SO (2004) Contraceptive use and behavior in the 21st century: a comprehensive study across five European countries. Eur J Contracept Reprod Health Care 9(2):57\u201368","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"8953_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107789","volume":"222","author":"AJ Bick","year":"2021","unstructured":"Bick AJ, du Louw- Toit R, Skosana SB, Africander D, Hapgood JP (2021) Pharmacokinetics, metabolism and serum concentrations of progestins used in contraception. Pharmacol Ther 222:107789","journal-title":"Pharmacol Ther"},{"key":"8953_CR13","unstructured":"Nations U (2019) Contraceptive use by method. New York, USA. 2019"},{"issue":"10","key":"8953_CR14","first-page":"2127","volume":"18","author":"Z Munn","year":"2020","unstructured":"Munn Z, Barker TH, Moola S, Tufanaru C, Stern C, McArthur A et al (2020) Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evid Synth 18(10):2127\u20132133","journal-title":"JBI Evid Synth"},{"key":"8953_CR15","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71","journal-title":"BMJ"},{"issue":"2","key":"8953_CR16","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0010-7824(93)90088-O","volume":"47","author":"L Villard-Mackintosh","year":"1993","unstructured":"Villard-Mackintosh L, Vessey MP (1993) Oral contraceptives and reproductive factors in multiple sclerosis incidence. Contraception 47(2):161\u2013168","journal-title":"Contraception"},{"issue":"12","key":"8953_CR17","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1111\/j.1471-0528.1998.tb10008.x","volume":"105","author":"M Thorogood","year":"1998","unstructured":"Thorogood M, Hannaford PC (1998) The influence of oral contraceptives on the risk of multiple sclerosis. BJOG 105(12):1296\u20131299","journal-title":"BJOG"},{"issue":"9","key":"8953_CR18","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1001\/archneur.62.9.1362","volume":"62","author":"\u00c1 Alonso","year":"2005","unstructured":"Alonso \u00c1, Jick SS, Olek MJ, Ascherio A, Jick H, Hern\u00e1n MA (2005) Recent use of oral contraceptives and the risk of multiple sclerosis. Arch Neurol 62(9):1362\u20131365","journal-title":"Arch Neurol"},{"issue":"6","key":"8953_CR19","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.fertnstert.2024.07.999","volume":"122","author":"A Nova","year":"2024","unstructured":"Nova A, Di Caprio G, Baldrighi GN, Galdiolo D, Bernardinelli L, Fazia T (2024) Investigating the influence of oral contraceptive pill use on multiple sclerosis risk using UK Biobank data. Fertil Steril 122(6):1094\u2013104","journal-title":"Fertil Steril"},{"key":"8953_CR20","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.msard.2018.01.019","volume":"20","author":"F Salehi","year":"2018","unstructured":"Salehi F, Abdollahpour I, Nedjat S, Sahraian MA, Memari A-H, Rahnama M et al (2018) Uncovering the link between reproductive factors and multiple sclerosis: a case-control study on Iranian females. Mult Scler Relat Disord 20:164\u20138","journal-title":"Mult Scler Relat Disord"},{"issue":"4","key":"8953_CR21","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00737-016-0600-1","volume":"19","author":"A Mohammadbeigi","year":"2016","unstructured":"Mohammadbeigi A, Kazemitabaee M, Etemadifar M (2016) Risk factors of early onset of MS in women in reproductive age period: survival analysis approach. Arch Womens Ment Health 19(4):681\u2013686","journal-title":"Arch Womens Ment Health"},{"issue":"3","key":"8953_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0149094","volume":"11","author":"K Hellwig","year":"2016","unstructured":"Hellwig K, Chen LH, Stancyzk FZ, Langer-Gould AM (2016) Oral contraceptives and multiple sclerosis\/clinically isolated syndrome susceptibility. PLoS One 11(3):e0149094","journal-title":"PLoS One"},{"issue":"6","key":"8953_CR23","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1212\/WNL.55.6.848","volume":"55","author":"MA Hern\u00e1n","year":"2000","unstructured":"Hern\u00e1n MA, Hohol MJ, Olek MJ, Spiegelman D, Ascherio A (2000) Oral contraceptives and the incidence of multiple sclerosis. Neurology 55(6):848\u2013854","journal-title":"Neurology"},{"issue":"7","key":"8953_CR24","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1016\/j.fertnstert.2010.06.045","volume":"94","author":"P Holmqvist","year":"2010","unstructured":"Holmqvist P, Hammar M, Landtblom A-M, Brynhildsen J (2010) Age at onset of multiple sclerosis is correlated to use of combined oral contraceptives and childbirth before diagnosis. Fertil Steril 94(7):2835\u20132837","journal-title":"Fertil Steril"},{"key":"8953_CR25","doi-asserted-by":"publisher","first-page":"58","DOI":"10.4103\/2008-7802.178532","volume":"7","author":"M Rejali","year":"2016","unstructured":"Rejali M, Hosseini SM, Kazemi Tabaee MS, Etemadifar M (2016) Assessing the risk factors for multiple sclerosis in women of reproductive age suffering the disease in Isfahan Province. Int J Prev Med 7:58","journal-title":"Int J Prev Med"},{"issue":"9","key":"8953_CR26","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1177\/13524585241258691","volume":"30","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Noyce AJ, Robson J, Giovannoni G, Marshall CR, Dobson R (2024) No association between oral contraceptive exposure and subsequent MS: a population-based nested case-control study in primary care. Mult Scler 30(9):1221\u20131226","journal-title":"Mult Scler"},{"issue":"12","key":"8953_CR27","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1111\/j.1471-0528.1998.tb10008.x","volume":"105","author":"M Thorogood","year":"1998","unstructured":"Thorogood M, Hannaford PC (1998) The influence of oral contraceptives on the risk of multiple sclerosis. BJOG Int J Obstet Gynaecol 105(12):1296\u20131299","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"13","key":"8953_CR28","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1177\/1352458515627205","volume":"22","author":"J Pakpoor","year":"2016","unstructured":"Pakpoor J, Wotton CJ, Schmierer K, Giovannoni G, Goldacre MJ (2016) Gender identity disorders and multiple sclerosis risk: a national record-linkage study. Mult Scler 22(13):1759\u20131762","journal-title":"Mult Scler"},{"issue":"1","key":"8953_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11910-023-01326-7","volume":"24","author":"S Hsu","year":"2024","unstructured":"Hsu S, Bove R (2024) Hormonal therapies in multiple sclerosis: a review of clinical data. Curr Neurol Neurosci Rep 24(1):1\u201315","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"7","key":"8953_CR30","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1177\/1474515120944014","volume":"19","author":"T Ruppar","year":"2020","unstructured":"Ruppar T (2020) Meta-analysis: how to quantify and explain heterogeneity? Eur J Cardiovasc Nurs 19(7):646\u2013652","journal-title":"Eur J Cardiovasc Nurs"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-08953-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-026-08953-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-08953-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T08:38:30Z","timestamp":1776242310000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-026-08953-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["8953"],"URL":"https:\/\/doi.org\/10.1007\/s10072-026-08953-1","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"13 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics approval"}},{"value":"Not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"340"}}